Trimethobenzamide Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Capsules / Injection
Available Strengths: 200 mg , 200 mg/mL
Reference Brands: Tigan (USA)
Category:
Antiemetic
Trimethobenzamide Hydrochloride is available in Capsules / Injection
and strengths such as 200 mg , 200 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Trimethobenzamide Hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Trimethobenzamide Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Trimethobenzamide is an antiemetic medication that works primarily as an antagonist of dopamine D2 receptors. Its therapeutic action is believed to occur at the chemoreceptor trigger zone (CTZ) located in the medulla oblongata of the brain. By blocking dopamine-mediated signals in this area, trimethobenzamide helps suppress the neural pathways responsible for triggering nausea and vomiting.
Through its targeted action on the central nervous system, trimethobenzamide is effective in controlling nausea and vomiting associated with various medical conditions, including postoperative recovery, gastrointestinal disturbances, and medication-induced emesis. Unlike some other antiemetic agents, trimethobenzamide has minimal effect on gastric motility, making it suitable for patients who require symptom relief without significant gastrointestinal stimulation.
Trimethobenzamide is commonly administered in oral or injectable form, depending on the severity of symptoms and clinical setting. The drug is generally well tolerated when used under medical supervision, although monitoring is recommended to manage potential central nervous system or anticholinergic side effects. Its established mechanism of action makes trimethobenzamide a reliable option in antiemetic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing